Genenta Science Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Public

  • Employees
  • 14

Employees

  • Stock Symbol
  • K5F

Stock Symbol

  • Share Price
  • $3.09
  • (As of Friday Closing)

Genenta Science General Information

Description

Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain, and TEMs -Immuno-Gene Therapy.

Contact Information

Website
www.genenta.com
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Stock Exchange
BER
Corporate Office
  • Dibit-San Raffaele Hospital
  • Via Olgettina 58
  • 20132 Milan
  • Italy
+39 335 000 0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Genenta Science Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$3.09 $3.16 $2.52 - $6.64 $60.1M 18.2M -$0.69

Genenta Science Financials Summary

In Thousands,
USD
TTM 31-Dec-2023 FY 2023 31-Dec-2023 FY 2022 31-Dec-2022 FY 2021 31-Dec-2021
EV 66,035 66,035 63,975 186,066
Revenue 0 0 0 0
EBITDA (12,890) (12,890) (8,946) (6,518)
Net Income (12,601) (12,601) (8,914) (6,537)
Total Assets 24,703 24,703 35,859 45,319
Total Debt 0 0 0 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Genenta Science Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Genenta Science‘s full profile, request access.

Request a free trial

Genenta Science Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene
Biotechnology
Milan, Italy
14 As of 2023
000.00
00000 0000-00-00
00000000 000.00

000000

ectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore ma
0000000000000
Worcester, MA
00 As of 0000
00000
00000000 00000

000000

fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in
0000000000000
Richmond, CA
000 As of 0000
00000
00000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Genenta Science Competitors (6)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Mustang Bio Corporation Worcester, MA 00 00000 00000000 00000
Sangamo Therapeutics Formerly VC-backed Richmond, CA 000 00000 00000000 00000
Allogene Therapeutics Formerly VC-backed South San Francisco, CA 000 00.000 00000000 00.000
Bluebird Bio Formerly VC-backed Somerville, MA 000 00.000 000000000 00.000
Cellectis Formerly VC-backed Paris, France 000 00000 000000000 00000
To view Genenta Science’s complete competitors history, request access »

Genenta Science Executive Team (9)

Name Title Board Seat Contact Info
Richard Slansky Chief Financial Officer
Carlo Russo MD Chief Medical Officer & Executive
Barbara Regonini Executive
Bernhard Gentner Ph.D Co-Founder & Executive Scientific Board Member
Kenneth Anderson MD Member of Scientific Board
You’re viewing 5 of 9 executive team members. Get the full list »

Genenta Science Board Members (19)

Name Representing Role Since
Anthony Marucci Self Board Member 000 0000
Bernhard Gentner Ph.D Genenta Science Co-Founder & Executive Scientific Board Member 000 0000
Guido Guidi Self Board Member 000 0000
Lisa Coussens MD Genenta Science Scientific Board Member 000 0000
Lucio Rovati MD Fidim Board Observer 000 0000
You’re viewing 5 of 19 board members. Get the full list »

Genenta Science Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Genenta Science Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Genenta Science‘s full profile, request access.

Request a free trial

Genenta Science FAQs

  • When was Genenta Science founded?

    Genenta Science was founded in 2014.

  • Who is the founder of Genenta Science?

    Bernhard Gentner Ph.D, Pierluigi Paracchi, and Luigi Naldini Ph.D are the founders of Genenta Science.

  • Who is the CEO of Genenta Science?

    Pierluigi Paracchi is the CEO of Genenta Science.

  • Where is Genenta Science headquartered?

    Genenta Science is headquartered in Milan, Italy.

  • What is the size of Genenta Science?

    Genenta Science has 14 total employees.

  • What industry is Genenta Science in?

    Genenta Science’s primary industry is Biotechnology.

  • Is Genenta Science a private or public company?

    Genenta Science is a Public company.

  • What is Genenta Science’s stock symbol?

    The ticker symbol for Genenta Science is K5F.

  • What is the current stock price of Genenta Science?

    As of 24-May-2024 the stock price of Genenta Science is $3.09.

  • What is the current market cap of Genenta Science?

    The current market capitalization of Genenta Science is $60.1M.

  • Who are Genenta Science’s competitors?

    Mustang Bio, Sangamo Therapeutics, Allogene Therapeutics, Bluebird Bio, and Cellectis are some of the 6 competitors of Genenta Science.

  • What is Genenta Science’s annual earnings per share (EPS)?

    Genenta Science’s EPS for 12 months was -$0.69.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »